(Q36200678)

English

A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 August 2017

0 references

1 reference

Europe PubMed Central

A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal (English)

1 reference

Europe PubMed Central

12 August 2017

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Choy EH

1

1 reference

Europe PubMed Central

12 August 2017

Smith C

2

1 reference

Europe PubMed Central

12 August 2017

Doré CJ

3

1 reference

Europe PubMed Central

12 August 2017

Scott DL

4

1 reference

Europe PubMed Central

12 August 2017

publication date

19 July 2005

1 reference

Europe PubMed Central

12 August 2017

1 reference

Europe PubMed Central

12 August 2017

44

1 reference

Europe PubMed Central

12 August 2017

11

1 reference

Europe PubMed Central

12 August 2017

1414-1421

1 reference

Europe PubMed Central

12 August 2017

The therapeutic approach of early intervention for rheumatoid arthritis: what is the evidence?

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

Combination therapy with disease modifying anti-rheumatic drugs in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

Combination therapy in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

Rational use of new and existing disease-modifying agents in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

Combinations of conventional disease-modifying antirheumatic drugs

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

Current and future management approaches for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

Combination of methotrexate and sulphasalazine in patients with rheumatoid arthritis: pharmacokinetic analysis and relationship to clinical response

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

Radiographic assessment of disease progression in rheumatoid arthritis patients enrolled in the cooperative systematic studies of the rheumatic diseases program randomized clinical trial of methotrexate, auranofin, or a combination of the two.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

Combination of methotrexate and sulphasalazine vs methotrexate alone: a randomized open clinical trial in rheumatoid arthritis patients resistant to sulphasalazine therapy.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

Controlled trial of hydroxychloroquine and D-penicillamine singly and in combination in the treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

Double blind placebo controlled trial of pulse treatment with methylprednisolone combined with disease modifying drugs in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

Combination Therapy with Cyclosporine and Methotrexate in Severe Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

Hydroxychloroquine and sulphasalazine alone and in combination in rheumatoid arthritis: a randomised double blind trial

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

Combination therapy with methotrexate and chloroquine in rheumatoid arthritis. A multicenter randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

Combination therapy with gold and hydroxychloroquine in rheumatoid arthritis: a prospective, randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

Combined D-penicillamine and chloroquine treatment of rheumatoid arthritis--a comparative study

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

Comparison of auranofin, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

Does steroid pulsing influence the efficacy and toxicity of chrysotherapy? A double blind, placebo controlled study

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

A randomized, double-blind, multicenter, controlled clinical trial of cyclosporine plus chloroquine vs. cyclosporine plus placebo in early-onset rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

Radiographic progression in early rheumatoid arthritis: a 12-month randomized controlled study comparing the combination of cyclosporin and methotrexate with methotrexate alone

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

Resolved: Low-dose glucocorticoids are neither safe nor effective for the long-term treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

The efficacy and toxicity of combination therapy in rheumatoid arthritis. a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEI031

21 January 2018

Identifiers

10.1093/RHEUMATOLOGY/KEI031

1 reference

Europe PubMed Central

12 August 2017

release_tteqd5eumvet5pgjdurssvvhk4

1 reference

https://api.fatcat.wiki/v0/release/tteqd5eumvet5pgjdurssvvhk4

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36200678&oldid=1836999233"